The criteria for qualifying tumors into LA and LB molecular subtypes are based on the expression of steroid receptors (estrogen and progesterone), HER2 and Ki-67 evaluated in the tumor tissue on histopathological examination. This evidence concerns the gene ERBB2 and neoplasm.